Rosetta Biosoftware
Seattle
About Rosetta Biosoftware
Rosetta Biosoftware provides life science informatics solutions that enable breakthroughs in basic biological research, drug discovery and development, and translational medicine. Their products accelerate research and improve safety and therapeutic decision making. We continue to innovate leading technology that converts data into understanding in support of the promise of personalized medicine. Rosetta Biosoftware was formerly a subsidiary of [Merck](http://www.merck.com), and was sold to Microsoft in June 2009.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Website: rosettabio.com
- Phone: 1 206.926.1200
Social Profiles
Canonical: https://fsome.com/organization/rosetta-biosoftware-1988105 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.